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Abstract: Injuries of bone and cartilage constitute important health issues costing the National Health
Service billions of pounds annually, in the UK only. Moreover, these damages can become cause of
disability and loss of function for the patients with associated social costs and diminished quality of
life. The biomechanical properties of these two tissues are massively different from each other and
they are not uniform within the same tissue due to the specific anatomic location and function. In this
perspective, tissue engineering (TE) has emerged as a promising approach to address the complexities
associated with bone and cartilage regeneration. Tissue engineering aims at developing temporary
three-dimensional multicomponent constructs to promote the natural healing process. Biomaterials,
such as hydrogels, are currently extensively studied for their ability to reproduce both the ideal 3D
extracellular environment for tissue growth and to have adequate mechanical properties for load
bearing. This review will focus on the use of two manufacturing techniques, namely electrospinning
and 3D printing, that present promise in the fabrication of complex composite gels for cartilage and
bone tissue engineering applications.
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1. Tissue Engineering
Defects that affect tissues such as cartilage or bone can be irreversible and become a clinical
challenge. This is particularly true when these lesions are associated with conditions such as
osteoarthritis and osteoporosis. Currently, it is estimated that 75 million people suffer of osteoporosis
in Europe, USA and Japan [1], while 27 million are affected by osteoarthritis in USA only [2].
These numbers are certainly due to increase, as the population is aging, leading to higher healthcare
costs. Current treatments for bone (i.e., autografts and allografts) present drawbacks such as limited
availability of donor tissue, risk of infection and unsatisfactory lesion repair [3], whilst the use of bone
graft substitutes are not as reliable as gold standard autograft. For small cartilage defects autologous
chondrocyte implantation, mosaic pasty and autologous matrix-induced chondrogenesis can be used
with variable success but for larger cartilage defects, often joint replacement is the only solution.
Therefore, new strategies are needed to repair damaged cartilage and bone tissue [4].
Tissue engineering is a promising interdisciplinary approach in this field: it aims at developing
temporary 3D multicomponent scaffolds that mimic the natural tissue, working as a porous framework
for the migration, adhesion and growth of cells to replace the damaged biological material. Ideally, a
scaffold for tissue regeneration should have a highly interconnected porous network for the diffusion of
nutrients and gases, have good mechanical properties in loadbearing conditions and degrade without
producing toxic products with increasing formation of new tissue [3].
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2. Challenges in Tissue Engineering of Soft and Hard Tissues
Tissue engineering has become one of the most commonly used approaches for cartilage and
bone tissue repair [5–8]. Even though these two tissues are important constituents of the skeletal
system, their structure and mechanics differ considerably. Bone is a hard and rigid tissue, whereas
cartilage is soft, viscoelastic and flexible and these two tissues are different in several aspects [9].
In addition, according to the anatomic location and function, the same type of tissue can be
heterogeneous displaying different anisotropic properties, biochemistry and cellular activity [10].
These characteristics complicate the fabrication of scaffolds that successfully mimic the structural and
mechanical characteristics of the target tissue.
2.1. Cartilage
Cartilage is a strong and elastic connective tissue that covers the articulating surface of the bone
in diarthrodial joints (articular cartilage) and is a structural component of the rib cage, ear, nose and
other body components [11]. Three types of cartilage exist, according to the extracellular matrix
(ECM) composition: elastic cartilage (if elastic fibres are present in the ECM), fibrous cartilage (if the
matrix is rich in collagenous fibres) and hyaline cartilage if the matrix is predominantly composed of
glycosaminoglycans, (GAGs). The latter, also known as articular cartilage, if found at the interface
between the gliding bony surfaces in the articular synovial joints, provides a deformable low-friction
surface that facilitates the movement of articulating bones and supports high dynamic compressive
loads [12]. Mechanically, human cartilage presents the following characteristics: compressive modulus
of 0.7–0.8 MPa, shear modulus of 0.7 MPa and tensile modulus of 0.3–10 MPa [13]. At the microscopic
scale, human cartilage consists of an ECM, which can be mineralized and is produced and maintained
by chondrocytes embedded within it. The hydrated ECM is composed of proteoglycans consisting of a
core protein with covalently attached GAGs, mainly chondroitin sulphates, and collagen type II [14].
The GAGs are responsible for the cartilages’ ability to support high compressive loads, whereas the
collagen II fibrils contribute to its high tensile strength and ability to tolerate shear stresses. Cartilage
composition includes 80% of water, drawn into the collagen II fibrils by the hydrophilic proteoglycan
complexes; this plays an important role in defining the tissue load-bearing function [12]. As cartilage
is compressed, the extracellular matrix is compacted causing the efflux of water. As the cartilage
is compacted more, the flow of water is reduced due to increasing drag increasing the hydrostatic
pressure, which withstands the load. It is important to note that cartilage is avascular, which means
that nutrients and cells infiltration is poor and wound healing, after injury or trauma, is hindered.
In particular, fibrocartilage is formed to replace the native cartilage and this new tissue is functionally
and biomechanically inferior to the native one. Current therapies to facilitate cartilage regeneration
include autografting, microfractures and autologous chondrocyte implantation (ACI); however, they
all present drawbacks and are unable to fully restore the functional hyaline cartilage, making long-term
prognosis uncertain [15]. For instance, autografting causes donor site morbidity and is limited by
donor tissue availability. Microfracture treatments can extend the damage to the surrounding tissue
and stem cells implantation can still induce the formation of fibrocartilage. In this scenario, cartilage
tissue engineered (CTE) scaffolds could be a turning point.
2.2. Bone
Bone is the main constituent of the musculoskeletal system [16] and differs from other connective
tissues (i.e., cartilage, ligaments and tendons) in rigidity and hardness [17] due to high mineralization
of its ECM [18]. Bone provides stiffness to the skeleton allowing for the shape of the body to be
maintained, plays a role in the transmission of muscular forces for movement, affords protection
to soft tissues within the cranial, thoracic and pelvic cavities as well as the bone marrow [19,20].
At the microscopic scale, bone is arranged in two architectural forms: trabecular and cortical bone.
Trabecular bone represents 20% of the skeletal mass and forms the inner part of the bone, it presents
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high porosity (50–90%) and contributes to mechanical support in bones such as the vertebrae. Cortical
bone, the dense outer layer of bone, comprises 80% of the weight of the human skeleton, and its
function is to provide mechanical strength and protection [16]. Mechanically, the bone presents the
following characteristics: the compressive strength for cortical bone ranges from 170 to 193 MPa
and its elastic modulus is found to be in the range of 7–20 GPa. Trabecular bone, however, has a
compressive strength ranging from 2 to 12 MPa and its modulus is in the range of 0.1–5 GPa [21,22].
Bone tissue presents a highly complex and hierarchical structure [23] which can be defined as a
nanocomposite consisting of inorganic nanocrystalline hydroxyapatite (HAp), organic components
(mainly type-I collagen) and water [24]. The nanocomposite structure is essential to provide the
required compressive strength and high toughness of the bone [25]. Collagen fibres reinforced
by HAp crystals form a tough and flexible nanostructured extracellular matrix, which supports
adhesion, proliferation, and differentiation of bone cells (osteoblasts, bone lining cells, osteocytes,
and osteoclasts) [19,26,27]. Bone constantly undergoes remodelling during life to help it adapt to
loading conditions; remove old, microdamaged bone replacing it with new, mechanically stronger
bone; and help to preserve bone strength [28]. This remarkably dynamic structure of bone displays
exceptional regenerative properties [29]; however, non-union fractures, tumour resections and some
musculoskeletal diseases can lead to critical size bone defects [30] that cannot heal spontaneously and
require additional treatment before they can regenerate [31]. Bone is the most commonly transplanted
tissue after blood [32]. Several therapeutic approaches including bone grafting procedures [33],
implantation of different biomaterials [34] and application of hormones or growth factors have been
investigated [35]. However, there is still no effective treatment for most cases [36,37]. The limitations
of autografting and allografting were previously addressed [38,39]. Metal implants provide immediate
mechanical support, but present limitations due to poor integration with the tissue, infection and
fatigue fracture [40,41]. Furthermore, ceramic bone graft substitute materials present very low tensile
strength and are brittle, restricting their use in locations of significant torsion, bending or shear
stress [42]. In this perspective, bone tissue engineering (BTE) has emerged as a promising approach for
bone reconstitution, overcoming the limitations of traditional implants [43–45].
2.3. Osteochondral Tissue
Osteochondral (OC) tissue is located at the interface between the osseous and the chondral
tissue and it promotes their interplay; its role and location require a complex composition
that includes cartilage, calcified cartilage and subchondral bone. The mechanical, structural and
biochemical characteristics of the osteochondral tissue vary throughout. For instance, from a
biochemical point of view, mineral content increases from cartilage to bone, while collagen and water
concentration diminishes. Structurally, pore size, porosity and vascularization increase from cartilage
to bone face. Mechanically, compressive modulus increases from cartilage to osseous tissue [46].
Osteochondral defects (OCDs) seem to play an important role in the genesis of joint diseases, such as
osteoarthritis or osteochondritis dissecans. Moreover, subchondral bone includes unmyelinated free
nerve endings which may cause pain in case of OC degeneration, due to the applied forces from
surrounding tissues [47]. This said, it is fundamental to repair osteochondral defects to prevent joint
destruction. However, OCDs are extremely difficult to treat due to the widely different features
between articular cartilage, calcified cartilage and subchondral bone [48]. Osteochondral scaffolds
should be designed to concurrently rehabilitate these three tissues all together. Several approaches
have been studied to promote OC regeneration, such as debridement, bone marrow stimulation
techniques, and the use of osteochondral allografts. However, these present strategies are affected
by many drawbacks. For instance, microfractures may lead to degeneration of the repaired tissue
and formation of the non-functional fibrocartilage. In the case of grafting techniques, there is lack
of donor tissue or immunoreactions. Considering the complexity of this tissue, more research into
osteochondral engineering is required [46,49].
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3. Hydrogels as Tissue Engineering Scaffolds
Hydrogels have been widely investigated not only for tissue engineering applications, but
also for drug delivery and wound dressing [4,50,51]. They are insoluble hydrophilic polymeric
networks that can swell without disintegrating and absorb a high degree of water, up to several
times their dry weight [52]. Their fully hydrated 3D structure resembles the extracellular matrix of
native tissues, both physico-chemically and biologically. Moreover, their porous structure enables
the transfer of nutrients and metabolites that are fundamental for cell growth. Hydrogels can be
formulated from different natural and synthetic polymers such as alginate, chitosan, fibrin, hyaluronic
acid (HA), poly(ethylene glycol) (PEG) and poly(ethylene oxide) (PEO). However, hydrogels often
show inadequate mechanical performance, due to the interstitial liquid and its plasticizing effect,
which make them too weak for applications in the musculoskeletal system [53]. For instance,
most hydrogels have an elastic modulus ranging from kPa to MPa, whereas native bone has a
modulus of ~1–20 GPa. Matching these properties is fundamental for two main reasons: (1) scaffolds
must support loads and movements; and (2) cells respond differently to different stresses, such
as compression, tension and shear [54]. Luckily, hydrogels are tuneable materials; their chemical
modification and differential crosslinking allow achieving the desired properties for the proposed
application. For example, it is possible to increase the hydrogel elastic modulus increasing crosslinks
density inside the gel or combining two or more independent networks, known as interpenetrating
networks. Numerous researchers have worked on finding ways to formulate hydrogel constructs
with optimized mechanical properties [55–57], and several techniques have been employed in
order to fabricate them [58]. Microfabrication techniques such as electrospinning and 3D printing
have emerged as promising strategies for manufacturing complex hydrogel structures for tissue
engineering applications.
4. Electrospinning
Electrospinning is a versatile, efficient, cheap and reproducible technique that can be used
to produce 1D fibrous materials or composites with a wide range of diameters (from nm to mm),
by applying an electrostatic force to a solution. Applications in tissue/organ repair and
regeneration [59], drug delivery [59], medical diagnostic, protective fabrics against environmental [60]
and infectious agents, and dental materials have all been studied [61]. A general electrospinning
apparatus (Figure 1) consists of three parts: a high voltage power supply device; a syringe/capillary
tube with a metallic needle; and a grounded metallic collector.
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In a typical electrospinning process, a polymeric solution (or melt) is loaded into a syringe and
ejected at a controlled rate, forming a drop (Figure 2a). Simultan ously, a high voltage (up to 2–30 kV,
depending on the solution used) is applied, and a charged jet of the polymeric solution or melt is
formed (Figure 2b–c). When the electrostatic repulsion starts to overcome the surface tension of the
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fluid, the hemispherical surface of the liquid will deform into a conical shape, called Taylor cone, at the
tip of the needle (Figure 2d). Finally, the solution jet starts to evaporate, and the polymer solidifies
creating a thin fibre jet that deposits on the grounded collector.
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The electrospinning of fibres is relatively complex, as the product characteristics can be influenced
by several parameters classed into three categori s:
1. Solution characteristics (viscosity, surface tension and conductivity): the electrospinning
technique relies on the uniaxial stretching of a charged jet, which, in turn, is significantly affected
by changing the concentration of the polymeric solution. Generally, by reducing the polymer
concentration, the fibre diameter is decreased. However, w en the conc nt ation of the polymeric
solution is lowered to a critical value, known as entanglement concentration (Ce), beaded fibres
are produced. If the concentration is too high no fibres are produced due to the excessive
viscosity [63]. Solution conductivity is fundamental to optimize both fibre diameter and stability
of the Taylor cone. If the solution has a low conductivity the fluid surface cannot be charged,
and no Taylor cone can be formed. By increasing the charge on the surface of the droplet a Taylor
cone is formed and the fibre diameter is decreased [64]. The conductivity of a polymeric solution
can be controlled by the addition of salts. Moreover, the solvent has a crucial role in determining
the charac er stics of the s lution; an ideal solvent must o b able to solubil ze the polymer at the
requi ed concentrations and be sufficiently volatile to evap rate in the space between the needle
and the collector. However, if the boiling point is too low, the solvent will evaporate too quickly
causing the drying of the jet at the needle tip [65].
2. Process parameters (applied voltage, flow rate and tip to collector distance): these parameters
influence the diameter and morphology of the fibres. As the feed rate increases, the charge density
will decrease. Thus, by increasing the flow rate the diameter of fibres is increased and beaded
morphology can be observed [64]. Fibres are formed just when the applied voltage is higher than
the threshold voltag (the value depend on the solution). Generally, by increasing the voltage
there is an increase of the electros atic force on the solution and thus, a reduction of the fibre
diameter. A critical distance between tip and collector is needed for the solvent eva oration and
for the preparation of smooth and uniform electrospun fibres. Generally, the longer the distance,
the thinner the fibres will be.
3. Environment conditions (humidity and temperature) [66,67]. Ideal environmental conditions
must be found for better and improved fibre production. Ambient humidity and temperature
can affect both the morphology and diameter of the fibres. Depending on the chemistry of the
polymer [68], the fibre diameter can increase or decrease and no definitive comparisons with
experimental data can be currently made.
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To date, many electrospun scaffolds made of polymers and inorganic nanoparticles have been
produced for tissue engineering applications. However, these electrospun scaffolds are in the
form of 2D mats (Figure 3b) with tightly packed fibres that negatively impact cell infiltration and
growth throughout the scaffold. Alternatively, scaffolds obtained by the amalgamation of fibres
and hydrogels can be used to achieve better properties, such as a well-interconnected porous
structures [69]. Different composite structures have been employed to fabricate fibrous hydrogels:
laminated composites (Figure 3c), encapsulating fibres into the hydrogels (Figure 3d), injectable
hydrogels, composite coatings and dual electrospun/electrospray composites [70].
Polyme s 2018, 10, x FOR PEER REVIEW  6 f 26 
 
hydrogels can be used to achieve better properties, such as a well-interconnected porous structures 
[69]. Different composite structures have been employed to fabricate fibrous hydrogels: laminated 
composites (Figure 3c), encapsulating fibres into the hydrogels (Figure 3d), injectable hydrogels, 
composite coatings and dual electrospun/electrospray composites [70]. 
 
Figure 3. (a) Architectural framework of a native extracellular matrix (ECM); (b) electrospun 2D mat; 
(c) laminated hydrogel; and (d) fibres encapsulated into a hydrogel. Reproduced from [71] with 
permission. Copyright (2011) PMC. 
4.1. Fibrous Hydrogels for Cartilage Tissue Engineering via Electrospinning 
Articular cartilage plays an important role in load-bearing joints during dynamic loading. When 
damaged, it cannot heal naturally, and clinical treatments are necessary. Tissue engineering aims at 
temporarily replacing damaged articular cartilage with 3D scaffolds. Hydrogels are promising 
materials for cartilage regeneration when strategies to reinforce their structure are applied, for 
example combining them with electrospun fibres. Indeed, these scaffolds can emulate the natural 
ECM (for its porosity and water content) and possess improved mechanical properties due to the 
fibres ability to reorient under deformation, stiffening, strengthening and toughening the system. 
Thus, researchers have tried to optimize the mechanical properties of the hydrogels, studying 
different parameters such as the polymers used, fibre diameter and alignment, porosity and mono or 
multi layered scaffolds.  
Many synthetic and natural polymers have been used for electrospun fibres for cartilage 
regeneration, such as polycaprolactone (PCL), poly(lactic-co-glycolic acid) (PLGA), poly(L-lactic acid) 
(PLLA), poly(vinyl alcohol) (PVA), Bombyx mori silk fibroin and chitosan. Chitosan, an amino 
saccharide that is biodegradable and cytocompatible, with antibacterial and wound healing activities 
as well as tissue-adhesive features has been one the most studied polymers. This polymer can be 
easily obtained by alkaline treatment of chitin, a naturally occurring polysaccharide obtained from 
the exoskeleton of crustaceans. To overcome chitosan poor mechanical properties, Mirahmadi et al. 
[72] developed a chitosan hydrogel enriched with electrospun silk fibroin fibres. They fabricated two 
gels, one with homogeneously dispersed chopped degummed silk fibres (SC/GP-D) and one as a 
three-layered composite with a layer of electrospun fibres sandwiched between two layers of chitosan 
gel (SC/GP-L). Results showed that the mechanical properties were generally enhanced by silk and 
that the laminated gel presented both better compressive and Young’s moduli compared to chitosan 
only (3.1 times stiffer) even though the mechanical performances were not as good as the natural 
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4.1. Fibrous Hydrogels for Cartilage Tissue Engineering via Electrospinning
Articular cartilage plays an important role in load-bearing joints during dynamic loading.
When damaged, it cannot heal naturally, and clinical treatments are necessary. Tissue engineering
aims at temporarily replacing damaged articular cartilage with 3D scaffolds. Hydrogels are promising
materials for cartilage regeneration when strategies to reinforce their structure are applied, for example
combining them with electrospun fibres. Indeed, these scaffolds can emulate the natural ECM (for its
porosity and water content) and possess improved mechanical properties due to the fibres ability to
reorient under deformation, stiffening, st engthening and toughening the system. Thus, researchers
have tried to optimize the mechanical properties of the hydrogels, studying different parameters such
as the polymers used, fibre iameter and alignment, porosity and mono or multi layered scaffolds.
Many synthetic and natural polymers have been used for electrospun fibres for cartilage
regeneration, such as polycaprolactone (PCL), poly(lactic-co-glycolic acid) (PLGA), poly(L-lactic acid)
(PLLA), poly(vinyl alcohol) (PVA), Bombyx mori silk fibroin and chitosan. Chitosan, an amino saccharide
that is biodegradable and cytocompatible, with antibacterial and wound healing activities as well as
tissue-adhesive features has been one the most studied polymers. This polymer can be easily obtained
by alkaline treatment of chitin, a naturally occurring polysaccharide obtained from the exoskeleton
of crustaceans. To overcome chitosan poor mechanical properties, Mirahmadi et al. [72] developed a
chitosan hydrogel enriched with electrospun ilk fibroin fibres. They fabricated two gels, ne with
homogeneously dispersed chopped degummed silk fibres (SC/GP-D) and one as a three-layered
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composite with a layer of electrospun fibres sandwiched between two layers of chitosan gel (SC/GP-L).
Results showed that the mechanical properties were generally enhanced by silk and that the laminated
gel presented both better compressive and Young’s moduli compared to chitosan only (3.1 times stiffer)
even though the mechanical performances were not as good as the natural cartilage. On the other
hand, the SC/GP-D scaffold was the best scaffold for cartilage formation (as shown by proteoglycan
and collagen II content) among the studied hydrogels [72]. For future studies, a combination of
both degummed fibres and nanofiber sheets could be examined to obtain improved mechanical
properties. A second possibility to improve the mechanical characteristics of the gel is to incorporate
individual and short electrospun nanofibers in hydrogel scaffolds, positioning them in a random way
to favour an irregular orientation of the chondrocytes. Mohabatbour and his group [73] fabricated PLA
fibres fragmented through aminolysis reaction to improve their hydrophobicity and cell-interaction
abilities. They fabricated an alginate grafted hyaluronic acid (Alg-HA) incorporating fragmented
PLA nanofibers. The nanofiber incorporated hydrogels had higher compressive modulus and lower
swelling ratio than Alg-HA hydrogel alone. In this case, the composite was cytocompatible and the
chondrocytes were able to maintain their functional properties producing GAGs and other extracellular
molecules. This research highlighted that, to control gel fracture and strength, fibres can be differently
oriented into a hydrogel.
Other studies have focused on introducing biological signals such as chondroitin sulphate
(CS), hyaluronic acid, and collagen, into tissue-engineered scaffolds to encourage tissue specificity.
Coburn et al. [74], for instance, fabricated poly(vinyl alcohol)-methacrylate (PVA-MA) fibrous scaffolds
with or without chondroitin sulphate, a signal that has been shown to enhance chondrogenesis of
mesenchymal stem cells. These hydrogels allowed for immediate cell infiltration, cartilaginous tissue
formation and chondrogenic differentiation (as indicated by a higher cartilage specific gene expression).
Finally, the addition of CS increased type II collagen deposition compared to PVA fibres alone [74].
More recently, solution electrospinning has been further developed into Melt Electrospinning
Writing (MEW), this exploits a layer-by-layer process similar to other 3D printing technologies affording
highly organised fibrous 3D structures in the micron scale. This process eliminates the need for
organic solvents that can induce cell toxicity and avoids mechanical and electrical coiling of the fibres
simplifying the manufacturing process. Using this technique, Bas et al. [75] produced a negatively
charged proteoglycan matrix with a star-shaped poly(ethylenglycol)/heparin hydrogel combined
with wet melted PCL fibres and deposited a 0◦–90◦ crosshatch architecture with different network
spacing. The best electrospun matrix had 600 µm spacing; its negative charge density and strong water
retention capacity, provided by PEG crosslinked heparin, accurately mimicked the natural cartilage
tissue in terms of electrochemical, mechanical and viscoelastic properties. The constructs presented
high chondrocyte viability and allowed for cell differentiation under physiologically relevant loading.
Even though the most common strategy is to form fibrous scaffolds with embedded fibres within
hydrogels, multilayer scaffolds constructed with fibres in different orientations have been investigated.
For instance, Tonsomboon et al. [76] studied how different designs of laminated and non-laminated
electrospun gelatin nanofibers in an alginate hydrogel could mimic the mechanical characteristics of
the collagenous ECM. In particular they have fabricated single layer composites (a) with or (b) without
a random orientation or multilayer composites with (c) unidirectional (where fibres had the same
orientation), (d) cross-ply (where alternating layers were perpendicular) or (e) angle-ply orientation
(where there were four different fibres orientations). Firstly, this work showed that nanocomposite
hydrogels were stronger and tougher than single polymer hydrogels. Secondly, aligned fibres increased
tensile strength without improving toughness. Thirdly, multilayer arranged nanofibers increased the
toughness by two orders of magnitude when compared to the controls [76]. Therefore, this paper
demonstrated that, by tuning different architectures of fibre reinforced and laminated composite
hydrogels, it is possible to resemble the mechanical properties of the native tissue. Literature on
hydrogels reinforced with electrospun fibres for cartilage regeneration is summarised in Table 1.
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Table 1. Publications on electrospun fibres reinforced hydrogels for cartilage regeneration.
Fibre(s) Hydrogel Fabrication method Mechanical properties Cytocompatibility Reference
PCL or
CSMA/PVAMA PEG-diacrylate
Fibres mixed with
the hydrogel Not reported
Chondrogenic
differentiation [71]
Polyacrylonitrile Alginate-polyacrylamide
Sandwich-like
structure
Young modulus:
3.4 MPa Not reported [77]
PDLA/PLLA or
PDLA/PCL Chitosan
Fibre infiltrated
with hydrogel
Compressive modulus:
2–12 MPa
Cartilage ECM
deposition [78]
PCL GelMA andGelMA/HAMA
Fibres infiltrated
with hydrogels
Compressive modulus:
20–1500 kPa Not reported [79]
PCL PEG-heparin Fibres infiltratedwith hydrogel
Compressive modulus:
10–1500 kPa
Cell viability > 80%
Chondrogenic
differentiation
[75]
PLA Alginate-graft-hyaluronate
Hydrogel mixed
fibres and gelled
Compressive modulus:
3–5.4 kPa
Cell viability > 85%
Chondrogenic
differentiation
[73]
SIlk Chitosan Sandwich-likestructure
Compressive modulus:
0.5–0.6 kPa
Cell viability > 90%
Chondrogenic
differentiation
[72]
PCL Alginate or alginatesulphate
Hydrogel pipetted
onto the scaffolds
Shear modulus:
0.5–5 kPa
Cartilage ECM
deposition [80]
4.2. Fibrous Hydrogels for Bone Tissue Engineering via Electrospinning
Hydrogels have been suggested as possible scaffolds for bone regeneration, but their poor
mechanical properties and low bioactivity make them inappropriate for hard tissue. One strategy is to
reinforce the gel with electrospun fibres, but only a few studies have been reported on fibrous scaffolds
for application in bone tissue engineering. Mehdi-Sahad et al. fabricated a 3D cell-laden three-layered
hybrid scaffold (Figure 4), incorporating a 2D mat layer of poly(hydroxybutyrate) (PHB) and
nano-hydroxyapatite fibres (diameter 2.0± 0.2 µm) between two layers of methacrylated gelatin/HAp.
As expected, the introduction of PHB/HAp fibres enhanced the mechanical strength (tensile modulus
7.0 ± 1.2 MPa, tensile strength 329 ± 18 kPa for the hybrid scaffold) and matrix mineralisation while
the hydrogel provided a biocompatible scaffold for cell penetration and proliferation. Even though
the mechanical properties were improved in comparison to the hydrogel only, they were still inferior
to the natural tissue. Thus, Sadat-Shojai and his group [69] suggested increasing the thickness of the
electrospun mat located at the centre of the scaffold, however this approach would lead to a denser
electrospun mat, with decreased porosity that would potentially hindered cell penetration into the
electrospun centre.
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A further problem encountered in bone grafting procedures is the development of infection,
inflammation and pain, intrinsically linked to any invasive procedure. However, due to poor
vascularity of the bone tissue, osteomyelitis is often difficult and costly to treat. For this reason.
injectable systems for minimally invasive procedure (MIP) have been developed. Calcium phosphate
cements are among the most used cements (e.g., Hydroset Accell 100™) for bone regeneration as
they are bioactive, and they have the ability of self-hardening. However, they are brittle, difficult to
inject and present limited porosity, therefore research has been focusing on replacing the cements with
injectable hydrogels. Liu et al. [81] have produced a biomimetic bone substitute made of chopped
poly(L-lactide-co-ε-caprolactone) nanoyarns manually incorporated in a collagen hydrogel before
gelation. Interestingly, to obtain well aligned nanoyarns, a water vortex was used as collector,
instead of more traditional systems as rotating drums or dual metal collection rings (Figure 5).
As a result, they obtained massive continuous nanoyarns with homogenous diameters (16 ± 4 µm).
Furthermore, the cut nanoyarns were short enough to avoid the formation of entanglements when
they were mixed with collagen solution. Results showed again that the incorporation of nanoyarns
improved the mechanical properties of the hydrogel, without interfering with the cell proliferative
ability of collagen.
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Another approach for promoting osteogenesis in comparison to just polymeric hydrogels is to
include growth factors inside the matrix. The scaffold needs to work as a delivery system promoting a
sustained release and improved local retention. Kolambkar et al. [83] introduced electrospun nanofiber
mesh tubes as a guide for rat bone regeneration in a segmental bone defect to deliver recombinant
bone morphogenetic protein-2 (rhBMP-2) (Fig re 6G). The PCL nanofibers (Figure 6A) had diameters
ranging fro 51 to 974 nm, with high porous meshes (80–90%). The thick nanofiber meshes were
able to be wrapped tightly around a steel mandrel and glued to form a tube (of 5 and 13 mm length)
that was finally put in a mouse bone defect (Figure 6D,E), as they were (Figure 6B) or after being
perforated (1 mm diameter perforations) (Figure 6C). Then, 125 µL pre-gelled 2% alginate with or
without 5 µg rhBMP-2 were injected in the tube lumen. As control groups, they examined the nanofiber
mesh alone and in combination with alginate hydrogel. Results showed that the systems containing
meshes + hydrogel + rhBMP-2 produced substantial bone formation and complete defect bridging,
while the controls did not exhibit any significant bone repair response. Indeed, defects were bridged
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by 12 weeks with densely packed, cellular mineralized tissue for both perforated and not perforated
meshes containing alginate loaded with rhBMP-2. However, micro-computed tomography (µCT)
revealed that perforations in mesh tubes enhanced bone formation at earlier stages in comparison
to the scaffolds without perforations. Moreover, samples implanted with both perforated mesh tube
and rhBMP-2 containing alginate were the only one presenting mechanical performances, in extracted
femora at 12 weeks, statistically similar to the ones of natural bone. They attributed this phenomenon
to the fact that the perforations allow sufficient vascularization to develop, while limiting soft tissue
ingrowth [83].
Polymers 2018, 10, x FOR PEER REVIEW  10 of 26 
 
bridging, while the controls did not exhibit any significant bone repair response. Indeed, defects were 
bridged by 12 weeks with densely packed, cellular mineralized tissue for both perforated and not 
perforated meshes containing alginate loaded with rhBMP-2. However, micro-computed 
tomography (μCT) revealed that perforations in esh tubes enhanced bone formation at earlier 
stages in comparison to the scaffolds without perforations. Moreover, samples implanted with both 
perforated mesh tube and rhBMP-2 containing alginate were the only one presenting mechanical 
performances, in extracted femora at 12 weeks, statistically similar to the ones of natural bone. They 
attributed this phenomenon to the fact that the perforations allow sufficient vascularization to 
develop, while limiting soft tissue ingrowth [83]. 
 
Figure 6. (A) SEM images of electrospun nanofiber mesh; (B) tubular implant without perforations; 
(C) tubular implant with perforations; (D) stabilized femur defect with implant; (E) bone defect, after 
placement of a perforated mesh tube; (F) alginate hydrogel was still present after 1 week, in vivo; and 
(G) release of rhBMP-2 from alginate hydrogel. Reproduced from [83] with permission. Copyright 
(2010) Elsevier. 
4.3. Fibrous Hydrogels for Osteochondral Engineering via Electrospinning 
The challenge in the development of OC scaffolds is that they should be able to replicate the 
complexity of this tissue, and therefore restore cartilage, intermediate calcified cartilage and bone 
tissues, all together. To achieve this result, composites scaffolds should be able to recruit 
mesenchymal cells from the bone marrow. Moreover, they must present a stratified structure in order 
to mimic the three different functional layers of OC tissue [46]. Hydrogel/fibre 3D composites have a 
great potential to mimic this complexity; however, to date, literature on graded or non-graded 
hydrogels with electrospun fibres for osteochondral regeneration is scarce. Single-phase composites 
have been used for instance by Coburn et al.; they fabricated poly(vinyl alcohol)-methacrylate (PVA-
MA) fibrous scaffolds with or without chondroitin sulphate, a signal that has been shown to enhance 
chondrogenesis of mesenchymal stem cells. These hydrogels, implanted into rat osteochondral bone 
defects, allowed for immediate cell infiltration, cartilaginous tissue formation and chondrogenic 
differentiation, as indicated by a higher cartilage specific gene expression. Furthermore, the addition 
of chondroitin sulphate increased type II collagen deposition compared to PVA fibres alone [74]. 
Figure 6. (A) SEM images of electrospun nanofiber mesh; (B) tubular implant without perforations;
(C) tubular implant with perforations; (D) stabilized femur defect with implant; (E) bone defect, after
placement of a p rforated mesh tube; (F) alginate hydrogel was still present after 1 week, in vivo; and
(G) release of rhBMP-2 from alginate hydrogel. Reproduced from [83] with permission. Copyright
(2010) Elsevier.
4.3. Fibrous Hydrogels for Osteochondral Engineering via Electrospinning
The challenge in the developm nt of OC scaffold is that they ould be able to repl cate the
complexity of this tissue, and ther fore restore cartilage, interm di te calcified artilage and bone
tissues, all together. To achieve this result, composites scaffolds should be able to recruit mesenchymal
cells from the bone marrow. Moreover, they must present a stratified structure in order to mimic
the three different functional layers of OC tissue [46]. Hydrogel/fibre 3D composites have a great
potential to mimic this complexity; however, to date, literature on graded or non-graded hydrogels with
electrospun fibres for steochondral regeneration is scarce. Single-phase c mp ites have bee used for
instance by Coburn et al.; they fabricated poly(vinyl alcohol)-methacrylate (PVA-MA) fibrous scaffolds
with or without chondroitin sulphate, a signal that has been shown to enhance chondrogenesis of
mesenchymal stem cells. These hydrogels, implanted into rat osteochondral bone defects, allowed for
immediate cell infiltration, cartilaginous tissue formation and chondrogenic differentiation, as indicated
by a higher cartilage specific gene expression. Furthermore, the addition of chondroitin sulphate
increased type II collagen deposition compared to PVA fibres alone [74]. Filovà et al. prepared a
PVA/liposomes blend that was electrospun and finally incorporated into a fibrin/type I collagen/fibrin
composite hydrogel. Compressive tests showed the addition of nanofibers improved the mechanical
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properties of the composite gel as predicted. Moreover, once implanted into osteochondral defects of
miniature pigs, the composite scaffold had better osteochondral regeneration towards hyaline cartilage
and/or fibrocartilage compared with the controls that were mainly filled with fibrous tissue [84].
5. 3D Printing
Three-dimensional (3D) printing refers to manufacturing techniques in which 3D models are built
in a computer-controlled layer-by-layer process [85]. It should be clarified that it is common to use
the term “3D printing” in literature and mainstream media when referring to all Rapid Prototyping
(RP) techniques; however, 3D printing also refers to a particular RP inkjet-based technology. The main
advantage of 3D printing techniques in tissue engineering relies on the possibility of generating
3D scaffolds with a precise control over the internal architecture [86,87]. Furthermore, fabrication
of scaffolds with a complex, subject-specific geometry by modelling data acquired using different
imaging techniques such as magnetic resonance imaging (MRI) or computed tomography (CT) scans
can be achieved [88]. Around 20 different 3D printing techniques have been applied to the biomedical
field [86]; however, not all of them are compatible for the processing of hydrogels. For an extensive
review in the hydrogel-rapid prototyping for tissue engineering the reader can refer to a recent
publication by Billiet et al. [89].
Briefly, 3D printing of hydrogels can be divided in three main methods: laser-based, nozzle-based,
and inkjet printer-based systems, depending on the stimuli employed to assist the printing process
and deposition of the material. Despite the differences in material deposition mechanism employed in
the different techniques, the typical apparatus includes a hydrogel reservoir from which the material
is transferred in a controlled manner to an ejection system and a collection platform. Nozzle- and
inkjet printers sequentially deposit material, while laser-based or laser-assisted systems are based on
photopolymerization of the pre-deposited material irradiated by light energy in specific predefined
patterns [90–92]. Nozzle-based or extrusion systems rely on a 3D dispensing process in which the
hydrogel is extruded through a nozzle driven by compressed air or a piston/rotating screw [93–95].
Electrical signals are used to control the ejection of individual droplets and/or direction of a sequence
of droplets [96,97].
These conventional 3D printing techniques are used to print cell-free 3D scaffolds for use in
surgery [98]. In recent years, 3D bioprinting has gained popularity in tissue engineering to allow the
direct one-step fabrication of 3D scaffolds containing biomaterials, cells and other biochemicals in
the same structure. The working principles of 3D bioprinting are similar to conventional 3D printing
techniques (Figure 7). The main difference lies on the deposition of the hydrogels together with
small units of cells. For a thorough review on the basic principles of bioprinting, readers can refer to
Mandrycky et al. [99].
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Figure 7. Illustration of 3D bioprinting technologies based on the mechanism used to assist the
deposition of the bioinks and its main components; (Left) Inkjet bioprinters eject small droplets of cells
and hydrogel sequentially to build up the scaffold; (Middle) Laser bioprinters use a laser to generate
the local ejection of small droplets from a donor ribbon coated with the bioink; (Right) Extrusion
bioprinters uses pneumatic of mechanical forces to continuously extrude the bioink through a nozzle.
Reproduced from [100] with permission. Copyright (2015) Wiley-VCH.
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Hydrogel inks used in 3D printing fabrication methods can be formulated from injectable,
shear-thinning hydrogels [101], as they are required to flow under low pressures, gel quickly,
and maintain their shape after build up [102]. When the hydrogel inks contain cells and/or
biochemicals for the use in bioprinting, they are referred as bioinks [103]. The design of hydrogel
inks for 3D printing starts with the formulation of a polymer solution that forms a connected network
soon after printing. The printed network can be physically or chemically cross-linked as a response to
external stimuli (e.g., temperature, light, and ion concentration) [104]. The development of hydrogel
inks suitable for bioprinting (both fabrication and cell culture), remains a challenge [105]. Whereas stiff
hydrogels containing high concentration of polymer are needed for optimal shape fidelity, these highly
dense networks limit cell migration, growth and differentiation [106,107]. Conversely, cells grow
better in soft hydrogels, which are too watery to maintain the desired shape (Figure 8). Maintaining
shape conformity may compromise the biological competence and the clinical outcomes of the printed
structures. Therefore, despite the advances in 3D printing technologies that allow researchers to
design and fabricate complex structures, the lack of suitable bioinks for tissue engineering is restricting
the progress in the field and its translation to clinical practice. Initially, 3D printing technologies
focused on the use of pure polymers; however, as the technology advances, the development of
novel composite-hydrogels for 3D printing are becoming increasingly popular, aiming at enhancing
properties such as printability, mechanics and bioactivity [108–111].
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Figure 8. Schematic of the challenges for engineering bioinks suitable for 3D printing. Optimal shape
fidelity can be typically achieved with stiff hydrogels (top right), however, this dense network limits
cell viability. Contrarily, cell survive best in soft hydrogels, but shape fidelity cannot be achieved
(bottom left). Therefore, a compromise between biological and fabrication properties must be done
(middle). Novel strategies aimed at obtaining high shape fidelity with cytocompatible hydrogels.
Reproduced from [105] with permission. Copyright (2009) Wiley-VCH.
5.1. 3D Printing of Hydrogels for Cartilage Tissue Engineering
Current scaffolds of 3D printing of hydrogels for CTE are mainly based on two different
approaches: direct printing from hydrogels and hybrid printing from composite-hydrogels [112].
The advantage of using bioinks composed of a unique hydrogel is based on their simpler printability
process compared to hybrid bioprinting and their physiological crosslinking conditions. Once again,
when a high-level of printability is needed from the bioink, the mechanical properties of the 3D
scaffolds are commonly weak [113], but the use of composite-hydrogels or the combination of a
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polymer network with bioinks can offer enough mechanical performance to support the 3D structure,
although it may reduce the bioactivity.
Both natural and synthetic hydrogels have been used for CTE applications using 3D printing,
where stem cells and chondrocytes are among the most common cell sources used in cartilage
bioprinting [114]. Alginate has been extensively used as a bioink due to its rapid crosslinking.
You et al. [113] successfully printed a porous cell-laden hydrogel scaffold using sodium alginate
impregnated with ATDC5 chondrogenic cell lines or primary chick chondrocytes as a bioink.
The resulting scaffolds supported cell survival (85% cell viability), proliferation and ECM deposition
of chondrogenic cells in vitro, however the compressive modulus was considerably low (20–70 kPa)
compared to human cartilage (700–800 kPa). The compressive modulus was enhanced (75–250 kPa)
in Markstedt et al. [115] by combining cellulose nanofibers with alginate. As a result, the printed
complex scaffolds supported the culture of human chondrocytes (73–86% viability after one and
seven days) as shown in Figure 9. The same bioink formulation (nanofibrillated cellulose/alginate) in
combination with human chondrocytes and MSCs was found to promote in vivo chondrogenesis after
subcutaneous implantation of the printed constructs in mice [116,117], suggesting the potential of 3D
bioprinting of human cartilage for clinical applications. On the other hand, cell viability (80–96%) and
cartilage ECM deposition was improved by Kesti et al. [118] by developing a cartilage-specific bioink
based on a blend of gellan and alginate and incorporating cartilage ECM particles and seeded with
bovine articular chondrocytes. 3D scaffolds were successfully printed with good mechanical properties
(tensile modulus: 116–230 kPa) and complex shapes (i.e., meniscus, intervertebral disks and nose).
Polymers 2018, 10, x FOR PEER REVIEW  13 of 26 
 
Both natural and synthetic hydrogels have been used for CTE applications using 3D printing, 
where stem cells and chondrocytes are among the most common cell sources used in cartilage 
bioprinting [114]. Alginate has been extensively used as a bioink due to its rapid crosslinking. You et 
al. [113] successfully printed a porous cell-laden hydrogel scaffold using sodium alginate 
impregnated with ATDC5 chondrogenic cell lines or primary chick chondrocytes as a bioink. The 
resulting scaffolds supported cell survival (85% cell viability), proliferation and ECM deposition of 
chondrogenic cells in vitro, however the compressive modulus was considerably low (20–70 kPa) 
compared to human cartilage (700–800 kPa). The compressive modulus was enhanced (75–250 kPa) 
in Markstedt et al. [115] by combining cellulose nanofibers with alginate. As a result, the printed 
complex scaffolds supported the culture of human chondrocytes (73–86% viability after one and 
seven days) as shown in Figure 9. The same bioink formulation (nanofibrillated cellulose/alginate) in 
combination with human chondrocytes and MSCs was found to promote in vivo chondrogenesis 
after subcutaneous implantation of the printed constructs in mice [116,117], suggesting the potential 
of 3D bioprinting of human cartilage for clinical applications. On the other hand, cell viability (80–
96%) and cartilage ECM deposition was improved by Kesti et al. [118] by developing a cartilage-
specific bioink based on a blend of gellan and alginate and incorporating cartilage ECM particles and 
seeded with bovine articular chondrocytes. 3D scaffolds were successfully printed with good 
mechanical properties (tensile modulus: 116–230 kPa) and complex shapes (i.e., meniscus, 
intervertebral disks and nose). 
 
Figure 9. 3D printed constructs made of a composite hydrogel (alginate + nanofibrillated cellulose) 
seeded with human chondrocytes. (A) 3D printed small grids (7.2 × 7.2 mm2). Deformed grid during 
(B), and after (C) squeezing. (D) 3D printed human ear. (E, F) 3D printed sheep meniscus. Reproduced 
from [115] with permission Copyright (2015) American Chemical Society. 
Hyaluronic acid (HA) is gaining popularity as a bioink for CTE because of its viscoelastic and 
bioactive properties [119]. However, HA on its own has poor mechanical properties and it is therefore 
necessary to add other materials to improve printability and performance., Muller et al. [120] and 
Pescosolido et al. [121] demonstrated increased viability of chondrocyte cells by adding acrylated 
Pluronic and a dextran derivate to HA. 
Gelatin has also shown excellent biocompatibility, but due to its low viscosity it is hard to print 
[122]. Therefore, gelatin is usually modified with an acrylate or methacrylate agent [123,124]. Gelatin-
methacrylamide hydrogels (GelMA) have been extensively used to produce bioinks for CTE [125–
127]. Schuurman et al. [127] demonstrated that introducing HA increased the printability and 
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(B), and after (C) squeezing. (D) 3D printed human ear. (E, F) 3D printed sheep meniscus. Reproduced
from [115] with permission Copyright (2015) American Chemical Society.
Hyaluronic acid (HA) is gaining popularity as a bioink for CTE because of its viscoelastic and
bioactive properties [119]. However, HA on its own has poor mechanical properties and it is therefore
necessary to add other materials to improve printability and performance., Muller et al. [120] and
Pescosolido et al. [121] demonstrated increased viability of chondrocyte cells by adding acrylated
Pluronic and a dextran derivate to HA.
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Gelatin has also shown excellent biocompatibility, but due to its low viscosity it is hard to
print [122]. Therefore, gelatin is usually modified with an acrylate or methacrylate agent [123,124].
Gelatin-methacrylamide hydrogels (GelMA) have been extensively used to produce bioinks for
CTE [125–127]. Schuurman et al. [127] demonstrated that introducing HA increased the printability
and bioactivity of the 3D printed scaffolds, with high chondrocyte cells viability (82% after 3 days).
Costantini et al. [126] showed that incorporating HA-methacrylate also enhanced the mechanical
properties (compressive modulus ranging from 48 kPa for GelMA to 100 kPa for the composite
bioink). On the other hand, Levato et al. [125] investigated different cell-sources to impregnate the
GelMA-based hydrogels. They concluded that the use of articular cartilage-resident chondroprogenitor
cells (ACPCs) as an alternative or in combination with chondrocytes and mesenchymal stromal cells
(MSCs) supported the formation of 3D cartilage scaffolds in vitro.
Poly(ethylene-glycol) (PEG) is one of the most common synthetic hydrogels used for 3D printing in
CTE, showing higher mechanical properties compared to natural hydrogels. Cui et al. [128] successfully
3D printed PEG-dimethacrylate (PEGDMA) with human chondrocytes reaching a compressive
modulus of 396 kPa and high cell viability (89%). In addition, Gao et al. [129] combined PEG with
GelMA and both hydrogels were printed together with human MSCs, demonstrating an improvement
of the mechanical properties after chondrogenic differentiation.
The relative weak mechanical properties of all the above-mentioned hydrogel constructs
considerably limit their application. To overcome this problem, alternating the printing of bioinks
and thermoplastic polymers fibres is becoming more popular in CTE [130]. 3D printed scaffolds have
been created by combining the deposition of a stiff polymer (polycaprolactone, PCL) and cell-laden
hydrogel (alginate) [130–132], with chondrocyte cell viability varying from 70% to 85%. In vivo studies
by Kundu et al. [131] showed enhanced cartilage ECM deposition by addition of transforming growth
factor-β (TGFβ). Furthermore, Schuurman et al. [130] reported a compressive modulus of 6000 kPa of
the printed hydrogels constructs.
5.2. 3D Printing of Hydrogels for Bone Tissue Engineering
Natural biopolymer hydrogels are excellent bioinks for 3D printing, due to their easily adjustable
materials characteristics such as viscosity or gelation kinetics as well as their capacity to provide
biocompatibility resulting in a consistency similar to the soft tissue matrix [133], however their
weak mechanical properties limits the support of osteogenic differentiation and therefore their use
for BTE [134,135]. Adjusting the scaffold composition is essential for the fabrication of bone tissue
constructs. Composite hydrogel-based materials consisting of an hydrogel phase mimicking the
organic part of the bone (mainly collagen type I) and a mineral phase representing the mineral content
of bone (mainly hydroxyapatite) [136–138] can enhance the mechanical properties of the 3D scaffolds
and their regenerative potential [139,140]. Natural (e.g., collagen, alginate, chitosan, HA, gelatin,
and agarose) and synthetic (PEG) hydrogels have been used as bioinks for BTE applications, with the
addition or not of inorganic particles (e.g., HAp).
HA is abundantly present in bone ECM, where it gives mechanical support. When it is modified
with methacrylate groups, resulting in methacrylated HA (MeHA), printability and rigidity improve
while maintaining good biocompatibility [141]. Poldevaart et al. [141] showed that human bone
marrow derived MSCs survival (64% after 21 days) and osteogenic differentiation, measured by
quantification of calcium deposition, were successfully achieved in 3D printed MeHA scaffolds;
however, the elastic modulus of the hydrogel was very low (10.6 kPa) compared to bone tissue.
MSC osteogenic differentiation and mechanical properties were enhanced [142] by combining agarose
hydrogels with collagen type I. Different combinations of agarose-collagen were tested showing
high cell viability (over 98%) and a compressive modulus ranging from 18 to 89 kPa. The less stiff
hydrogel exhibited a higher MSC osteogenic differentiation in vitro. In vivo bone matrix formation
was observed [143] after implantation of 3D printed alginate-gelatin scaffolds seeded with human
adipose-derived stem cells (hASCs). Despite the good biocompatibility and osteogenic differentiation,
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using 3D printed hydrogel scaffolds without the addition of any inorganic particle notably affects the
mechanical properties.
Early attempts to enhance the performance of the printed hydrogels by incorporating HAp
particles by Ang et al. [144] used a chitosan-HAp composite and showing cell biocompatibility.
However, osteogenesis and mechanics were not evaluated, and cells were not printed together with
the hydrogels. More recently, 3D printed cell-laden scaffolds using different hydrogel formulations
(e.g., chitosan, alginate, and gelatin) with HAp particles have been studied [145,146]. The incorporation
of HAp particles significantly improved the mechanical strength of the hydrogels and promoted
osteogenic differentiation in vivo [140,145–147], making them suitable for repairing bone tissue defects
(Figure 10).
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Figure 10. 3D bio-printed constructs made of alginate/gelatin (AG) and alginate/gelatin/nano-HAp
(AGH) mixed with human adipose-derived stem cells (hASCs) before and after implantation showing
osteoinduction. Constructs were implanted into the back sub-cutaneous area of nude mice and
harvested eight weeks after surgery. Larger bone formation was observed in the constructs containing
HAp. Reproduced from [140] with permission, Copyright (2016) Royal Society of Chemistry.
Although hydrogels and composite-hydrogels have shown to be suitable for application in low
load-bearing bone defects, adequate mechanical properties are still needed. In this perspective, hybrid
scaffolds combining synthetic polymer scaffolds and cell-laden hydrogels are a promising area to
explore. PCL is commonly used for bone scaffolds due to its high mechanical strength [98], but it
presents limited cell affinity [148]. To improve cell proliferation and enhance the osteogenesis of
PCL 3D printed scaffolds, Dong et al. [149] integrated them with bone marrow MSCs-laden chitosan
hydrogel, achieving a compressive strength of the hybrid scaffolds of about 6.7 MPa (similar to
trabecular bone). Osteogenesis was enhanced by incorporating chitosan into the PCL scaffolds and
in vivo bone formation was found after implantation of the seeded scaffolds in a mice model [149].
Vascularization of 3D printed bone constructs was studied by Kang et al. [150] and Kuss et al. [151].
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Cell laden hydrogels were hybrid bioprinted together with a PCL frame. Bone and vessel formation
was observed in vitro and in vivo, resulting in promising results for the regeneration of bone defects.
Works involving the use of 3D printing in the fabrication of scaffolds for bone and cartilage
regeneration are summarised in Tables 2 and 3. Even if these are not exhaustive lists of
publications, they highlight the progress done on the front of providing viable cells for implantation.
However, in vivo work is so far limited and needs to be explored more widely to bring these strategies
closer to clinical translation.
Table 2. Overview of publications on 3D printing of hydrogels for cartilage tissue engineering.
Material(s) Cell source(s) Printing method Mechanicalproperties Cytocompatibility Reference
Sodium alginate
ATDC5
chondrogenic cell
line
Inkjet bioprinting Compressivemodulus: 20–70 kPa
~85% cell viability
Cartilage ECM deposition [113]
Alginate with
cellulose nanofibers
Human nasoseptal
chondrocytes Inkjet bioprinting
Compressive
modulus: 75–250 kPa 73–86% cell viability [115]
Alginate with
cellulose nanofibers
Human nasoseptal
chondrocytes
Extrusion
bioprinting
Compressive stress:
15–88 kPa Cartilage ECM deposition [116]
Alginate with
cellulose nanofibers
Human nasoseptal
chondrocytes and
MSCs
Extrusion
bioprinting Not reported
Chondrogenic
differentiation
Chondrocytes
proliferation
[117]
Alginate with gellan Bovine articularchondrocytes
Extrusion
bioprinting
Tensile modulus:
116–230 kPa
80–96% cell viability.
Cartilage ECM deposition
Chondrocytes
proliferation
[118]
Methacrylated HA
with diacrylated
Pluronic
Bovine articular
chondrocytes Inkjet bioprinting
Compressive
modulus: 1.5–6.5 kPa 62–86% cell viability [120]
HA with dextran
derived
Equine articular
chondrocytes
Extrusion
bioprinting
Ultimate
compressive stress:
100–160 kPa
>75% cell viability [121]
GelMA with HA Equine articularchondrocytes Inkjet bioprinting
Compressive
modulus: 5–180 kPa >73% cell viability [127]
GelMA with
HA-methacrylate
Human bone
marrow MSCs
Extrusion
bioprinting
Compressive
modulus: 48–100 kPa
85–95% cell
viability.Chondrogenic
differentiation
[126]
GelMA Equine ACPCs/Chondrocytes/MSCs Inkjet bioprinting
Compressive
modulus:
100–187 kPa
>75% cell viability [125]
PEGDMA Human articularchondrocytes Inkjet bioprinting
Compressive
modulus: ~400 kPa
89% cell viability Cartilage
ECM deposition [128]
PEG-GelMA Human MSCs Inkjet bioprinting Compressivemodulus: ~1 MPa
~80% cell viability
Cartilage ECM deposition
Chondrogenic
differentiation
[129]
Alginate reinforced
with PCL
Embryonic chick
chondrocytes
Extrusion
bioprinting Not reported
77–85% cell viability
Cartilage ECM deposition [132]
Alginate reinforced
with PCL + TGFβ
Human nososeptal
chondrocytes
Extrusion
bioprinting Not reported
85% cell viability Cartilage
ECM deposition [131]
Alginate reinforced
with PCL
C20A4 human
chondrocyte cell line
Extrusion
bioprinting
Compressive
modulus: 6 MPa ~70% cell viability [130]
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Table 3. Overview of publications on 3D printing of hydrogels for bone tissue engineering.
Material(s) Cell source(s) Printing method Mechanicalproperties Cytocompatibility Reference
MeHA Human BM MSCs Inkjet bioprinting Elastic modulus:~11 kPa
~65% cell viability
Osteogenic differentiation [141]
Agarose with
collagen type I Human BM MSCs Inkjet bioprinting
Compressive
modulus: 18–90 kPa
>98% cell viability
Osteogenic differentiation [142]
Alginate-gelatin hASCs Inkjet bioprinting Not reported Osteogenic differentiationBone matrix formation [143]
Chitosan-HAp Human osteoblasts Extrusion printing Not reported Good cell attachment andproliferation [144]
Chitosan-HAp/
Alginate-HAp MC3T3-E1 Inkjet bioprinting
Elastic modulus:
4.6–15 kPa/
3.5–19 kPa
>90% cell viability Cell
proliferation Osteogenic
differentiation
[145]
MeHA with HAp or
GelMA with HAp hASCs
Extrusion
bioprinting Not reported
Osteogenic differentiation
Bone matrix formation [146]
Alginate-gelatin/
alginate-gelatin with
nano-HAp
hASCs Extrusionbioprinting Not reported
>88% cell viability
Osteogenic differentiation [140]
Alginate-polyvinyl
alcohol with HAp MC3T3-E1 cells
Extrusion
bioprinting
Compressive
modulus:
2.4–10.3 kPa
77–95% cell viability [147]
Chitosan reinforced
with PCL Rabbit BM MSCs
Extrusion
bioprinting
Compressive
strength: 6.7 MPa
Osteogenic differentiation
Bone matrix formation [149]
HA and Gelatin
reinforced with
PCL/TCP
Human amniotic
fluid-SCs
Extrusion
bioprinting Not reported
91% cell viability
Osteogenic differentiation
Bone matrix formation
[150]
MeHA and GelMA
reinforced with
PCL/HAp
Stromal vascular
fraction derived cells
Extrusion
bioprinting Not reported Osteogenic differentiation [151]
5.3. 3D Printing of Hydrogels for Osteochondral Tissue Engineering
3D printing of hydrogels has shown great potential for the production of customized scaffolds in
cartilage and bone tissue engineering, as previously described. Because of its ability to fabricate 3D
constructs with complex shapes by depositing cell laden hydrogels at desired locations, 3D printing
also results in a promising technique for the fabrication of gradient scaffolds with hydrogels stacked
in a multilayer manner [152]. This unique capability enables to expand the use of 3D printing
to the efficient regeneration of osteochondral tissue, providing a scaffold that favours integration
between the chondral and the osseous phases for osteochondral defects repair. 3D printed constructs
for osteochondral tissue regeneration are usually built in a bilayer fashion, by employing different
bioink formulations for the subchondral bone and the cartilage zone. Early attempts were done by
Fedorovick et al. [153] encapsulating human chondrocytes and osteogenic progenitors in alginate
hydrogel, biofabricating 3D scaffolds with different parts for both cell types. Distinctive tissue
formation at defined locations was observed both in vitro and in vivo, however, the scaffolds presented
low mechanical strength (Young’s modulus < 7.6 kPa) and a limited height of the construct could
be achieved. Anatomically relevant size bilayered scaffolds were fabricated by Levato et al. [154]
combining two different bioinks: GelMA-Gellan Gum with PLA microcarriers (MCs) seeded with
MSCs for the bone and without MCs for the cartilage layer. The MC laden region improved the
compressive modulus (25–50 kPa) of the hydrogel constructs and supported osteogenic differentiation
and bone matrix deposition by MSCs, suggesting the potential of the use of MCs-based biofabrication
for osteochondral tissue engineering. An efficient osteochondral gradient scaffolds was fabricated using
a novel laser-based 3D printer by Castro et al. [155] and human MSCs osteogenic and chondrogenic
differentiation was enhanced through the incorporation of tissue specific nano-HAp with different
concentrations of PEG-diacrylate (PEG-Da) for the porous osseous layer and the transitional calcified
cartilage layer, and TGF-β1 added to the PEG-Da for the solid cartilage layer. It is known that hydrogels
derived from natural ECM can enhance tissue regeneration by providing biochemical signals inducing
cellular differentiation and migration [156,157]. In this sense, HA and collagen type I (Col-I), which are
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the major organic ECM components of cartilage and bone, respectively, were combined in a 3D printed
scaffold fabricated by Park et al. [158]. A bilayer construct was 3D printed encapsulating chondrocytes
in a HA hydrogel for the cartilage zone and osteoblast in a Col-I hydrogel for the bone area within a
PCL printed framework. Viability and function of each cell type were well maintained up to 14 days
in vitro. A validation of the potential of a 3D printed bilayer construct for osteochondral tissue
regeneration using an in vivo animal model was reported by Shim et al. [159]. A subchondral bone
layer was fabricated by dispensing a solution of atelocollagen with human turbinate-derived MSCs
onto a PCL framework, whereas a solution of cucurbit [6] uril-HA and 1,6-diaminohexane-conjugated
HA was dispensed into the PCL matrix for the superficial cartilage layer. 3D printed scaffolds were
implanted in the knee joints of rabbits. Neo-cartilage was observed in the cartilage region and new
bone formation in the subchondral bone region at eight weeks post implantation.
6. Future Trends
Electrospinning and 3D printing both have a great potential in the fabrication of complex
structures such as those required for tissue engineering of bone, cartilage and osteochondral tissue.
Combining the two could also overcome some of the limitations of the individual methods such as the
tight intertwining of electrospun fibres that limits cell migration and the limited resolution of some
3D prototyping methods. The first reports of materials obtained by combining these two fabrication
methods have only emerged in recent years [160]. More specific reports on their combined use in the
manufacturing of tissue engineering scaffolds for bone, cartilage and osteochondral tissues are still
limited. Yu et al. prepared PCL printed meshes that were infused with homogenised electrospun
PCL/gelatine fibres crosslinked with glutarhaldehyde [161]. The work showed that combination of
the mechanically competent 3D printed mesh with the biocompatible nanofibers can be exploited
to obtain the ratio of porosity and the pore size that is most advantageous for cell migration and
proliferation. Naghieh et al. fabricated scaffolds with alternating layers of 3D printed PLA mesh
and gelatin/forsterite electrospun fibres [162]. These hierarchical structures presented appropriate
mechanical behaviour for applications in bone tissue engineering with additional bioactive properties.
These first reports demonstrate the potential of using a combinatorial approach, where 3D printing
and electrospinning can afford additive advantages to the use of a single technique. The translational
potential of this strategy must be now explored.
7. Conclusions
Hydrogels and their combination with other biomaterials are very attractive in tissue engineering
applications targeting both soft and hard tissue replacement, with specific relevance to orthopaedics.
To achieve complex hydrogel constructs with the necessary requirements to substitute the specific tissue
and help regeneration, two manufacturing techniques are currently considered the most promising
in the field: electrospinning and 3D printing. This review considers the most recent advances of
hydrogel-based scaffold production using such techniques applied to cartilage and bone tissue
engineering. As a result, a variety of materials can be used to fine-tune composite implants to
achieve the desired mechanical and biological properties. However, as it stands, both electrospinning
and 3D printing of hydrogel composites is still limited by the inability of selectively assign materials to
reproduce tissue geometry and properties with required resolution and further work is needed in this
sense, particularly to target tissue transition at the interface between bone and cartilage.
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